Clinical Trial Update: Intravitreal Bevacizumab vs Laser vs Combination of Bevacizumab and Modified Laser in PDR [Phase 2]

View source ↗

Summary

Phase 2 trial comparing intravitreal bevacizumab, laser therapy, and combination therapy for proliferative diabetic retinopathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Proliferative Diabetic Retinopathy

Drugs mentioned

• Bevacizumab (bevacizumab)
• Laser therapy

Snippet

Sponsor: Shahid Beheshti University of Medical Sciences | Conditions: Proliferative Diabetic Retinopathy | Phase 2 | Status: UNKNOWN